» Articles » PMID: 12915560

Comparative Study of Regulation of RTA-responsive Genes in Kaposi's Sarcoma-associated Herpesvirus/human Herpesvirus 8

Overview
Journal J Virol
Date 2003 Aug 14
PMID 12915560
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

Replication and transcription activator (RTA) (also referred to as ORF50), an immediate-early gene product of Kaposi's sarcoma-associated herpesvirus (KSHV)/(human herpesvirus 8), plays a critical role in balancing the viral life cycle between latency and lytic replication. RTA has been shown to act as a strong transcription activator for several downstream genes of KSHV. Direct binding of RTA to DNA is thought to be one of the important mechanisms for transactivation of target genes, while indirect mechanisms are also implicated in RTA transactivation of certain selected genes. This study demonstrated direct binding of the DNA-binding domain of RTA (Rdbd) to a Kaposin (Kpsn) promoter sequence, which is highly homologous to the RTA-responsive element (RRE) of the PAN promoter. We undertook a comparative study of the RREs of PAN RNA, ORF57, vIL-6, and Kpsn to understand how RTA regulates gene expression during lytic replication. Comparing RNA abundance and transcription initiation rates of these RTA target genes in virus-infected cells suggested that the transcription initiation rate of the promoters is a major determinant of viral gene expression, rather than stability of the transcripts. RTA-mediated transactivation of reporters containing each RRE showed that their promoter strengths in a transient-transfection system were comparable to their transcription rates during reactivation. Moreover, our electrophoretic mobility shift assays of each RRE demonstrated that the highly purified Rdbd protein directly bound to the RREs. Based on these results, we conclude that direct binding of RTA to these target sequences contributes to their gene expression to various extents during the lytic life cycle of KSHV.

Citing Articles

Unraveling the Kaposi Sarcoma-Associated Herpesvirus (KSHV) Lifecycle: An Overview of Latency, Lytic Replication, and KSHV-Associated Diseases.

Losay V, Damania B Viruses. 2025; 17(2).

PMID: 40006930 PMC: 11860327. DOI: 10.3390/v17020177.


Viruses and Skin Cancer.

Becerril S, Corchado-Cobos R, Garcia-Sancha N, Revelles L, Revilla D, Ugalde T Int J Mol Sci. 2021; 22(10).

PMID: 34065594 PMC: 8161099. DOI: 10.3390/ijms22105399.


Concurrent Control of the Kaposi's Sarcoma-Associated Herpesvirus Life Cycle through Chromatin Modulation and Host Hedgehog Signaling: a New Prospect for the Therapeutic Potential of Lipoxin A4.

Asha K, Balfe N, Sharma-Walia N J Virol. 2020; 94(9).

PMID: 32102879 PMC: 7163125. DOI: 10.1128/JVI.02177-19.


A herpesvirus transactivator and cellular POU proteins extensively regulate DNA binding of the host Notch signaling protein RBP-Jκ to the virus genome.

Gonzalez-Lopez O, DeCotiis J, Goyeneche C, Mello H, Vicente-Ortiz B, Shin H J Biol Chem. 2019; 294(35):13073-13092.

PMID: 31308175 PMC: 6721950. DOI: 10.1074/jbc.RA118.007331.


Activation and counteraction of antiviral innate immunity by KSHV: an Update.

Wei X, Lan K Sci Bull (Beijing). 2019; 63(18):1223-1234.

PMID: 30906617 PMC: 6426151. DOI: 10.1016/j.scib.2018.07.009.


References
1.
Zhong W, Wang H, Herndier B, Ganem D . Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. Proc Natl Acad Sci U S A. 1996; 93(13):6641-6. PMC: 39079. DOI: 10.1073/pnas.93.13.6641. View

2.
Lukac D, Kirshner J, Ganem D . Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells. J Virol. 1999; 73(11):9348-61. PMC: 112969. DOI: 10.1128/JVI.73.11.9348-9361.1999. View

3.
Memar O, Rady P, Tyring S . Human herpesvirus-8: detection of novel herpesvirus-like DNA sequences in Kaposi's sarcoma and other lesions. J Mol Med (Berl). 1995; 73(12):603-9. DOI: 10.1007/BF00196354. View

4.
Sun R, Lin S, Gradoville L, Miller G . Polyadenylylated nuclear RNA encoded by Kaposi sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A. 1996; 93(21):11883-8. PMC: 38153. DOI: 10.1073/pnas.93.21.11883. View

5.
Kedda M, Margolius L, Kew M, Swanepoel C, Pearson D . Kaposi's sarcoma-associated herpesvirus in Kaposi's sarcoma occurring in immunosuppressed renal transplant recipients. Clin Transplant. 1996; 10(5):429-31. View